Leishmania species: Models of intracellular parasitism

Journal of Cell Science

Volumn 112, Issue 18, 1999, Pages 2993-3002

  Alexander, James ^a   Satoskar, Abhay R ^b   Russell, David G ^c  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESSORY CELL; ANTIGEN PRESENTATION; DENDRITIC CELL; HOST PARASITE INTERACTION; IMMUNE RESPONSE; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; NOTE; PARASITE IMMUNITY; PRIORITY JOURNAL;

ANIMALS; ANTIGEN PRESENTATION; CYTOKINES; HOST-PARASITE RELATIONS; HUMANS; LEISHMANIA; MACROPHAGES; MICE; MODELS, BIOLOGICAL; TH1 CELLS; TH2 CELLS; VACUOLES;

LISTERIA MONOCYTOGENES; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; SALMONELLA TYPHIMURIUM; TOXOPLASMA GONDII; TRYPANOSOMA; TRYPANOSOMA CRUZI; TYPHIMURIUM;

EID: 0032883457     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (154)

1. Afonso, L. C. C. and Scott, P. (1993). Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 61, 2952-2959.
2. Afonso, L. C. C., Scharton, T. M., Vieira, L. Q., Wysocka, M., Trinchieri, G. and Scott, P. (1994). The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263, 235-237.
3. Alexander, J. and Vickerman, K. (1975). Fusion of host cell secondary lysosomes with the parasitophorous vacuoles of Leishmania mexicana infected macrophages. J. Protocol. 22, 502-508.
4. Alexander, J. and Russell, D. G. (1992). The interaction of Leishmania species with macrophages. Advan. Parasitol. 31, 175-254.
5. Alexander, J., Coombs, G. and Mottram, J. (1998). Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response. J. Immunol. 161, 6794-6801.
6. Al-Zamel, F., Al-Shammary, F. J., El-Shewemi, S. and Soliman, R. (1996). Enhancement of leishmanicidal activity of human macrophages against Leishmania major and Leishmania donovani infection using recombinant human granulocyte macrophage colony stimulating factor. Zentrabl. Bakteriol. 285, 92-105.
7. Antoine, J. C., Prina, E., Jouanne, C. and Bongrand, P. (1990). Parasitophorous vacuoles of Leishmania amazonensis-infected macrophages maintain an acidic pH. Infect. Immun. 58, 779-787.
8. Bahr, V., Stierhof, Y. D., Hg, T., Demar, M., Quinten, M. and Overath, P. (1993). Expression of lipophosphoglycan high-molecular weight phosphoglycan and glycoprotein 63 in promastigotes and amastigotes of Leishmania mexicana. Mol. Biochem. Parasitol. 58, 107-122.
9. Barral, A., Barral-Netto, M., Yong, E. C., Brownell, C. E., Twardzik, D. R. and Reed, S. G. (1993). Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proc. Nat. Acad. Sci. USA 90, 3442-3446.
10. Barral, A., Teixeira, M., Reis, P., Vinhas, V., Costa, J., Lessa, H., Bittencourt, A. L., Reed, S. and Carvalho, E. M. (1995). Transforming growth factor-β in human cutaneous leishmaniasis. Am. J. Pathol. 147, 947-954.
11. Belkaird, Y., Butcher, B. and Sacks, D. L. (1998). Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania infected cells. Eur. J. Immunol. 28, 1369-1400.
12. Blackwell, J. M., Ezekowitz, R. A. B., Roberts, M. B., Channon, J. Y., Sim, R. B. and Gordon, S. (1985). Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J. Exp. Med. 162, 324-329.
13. Blackwell, J. M. (1996). Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 112, S67-S74.
14. Blackwell, J. M. (1998). Genetics of host resistance and susceptibility to intramacrophage pathogens: a study of multicase families of tuberculosis, leprosy and leishmaniasis in north-eastern Brazil. Int. J. Parasitol. 28, 21-28.
15. Bogdan, C., Gessner, A., Solbach, W. and Rollinghoff, M. (1996). Invasion, control and persistence of Leishmania parasites. Curr. Opin. Immunol. 8, 517-525.
16. Bogdan, C. and Rollinghoff, M. (1998). The immune response to Leishmania: mechanisms of parasite control and evasion. Int. J. Parasitol. 28, 121-134.
17. Bozza, M., Soares, M. B. P., Bozza, P. T., Satoskar, A. R., Diacovo, T. G., Brombacher, F., Titus, R. G., Shoemaker, C. B. and David, J. R. (1998). The PACAP-type I receptor agonist maxadilan from sand fly saliva protects mice against lethal endotoxemia by a mechanism partially dependent of IL-10. Eur. J. Immunol. 28, 1811-1816.
18. Brittingham, A., Morrison, C. J., McMaster, W. R., McGwire, B. S., Chang, K. P. and Mosser, D. M. (1995). Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion and resistance to complement-mediated lysis. J. Immunol. 155, 3102-3111.
19. Brittingham, A. and Mosser, D. M. (1996). Exploitation of the complement system by Leishmania promastigotes. Parasitol. Today 12, 444-447.
20. Campbell, K. A., Overdale, P. J., Kennedy, M. K., Fanslow, W. C., Reed, S. G. and Maliszewski, C. R. (1996). CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4, 283-289.
21. Carrera, L., Gazzinelli, R. T., Badolato, R., Hieny, S., Muller, W., Kuhn, R. and Sacks, D. L. (1996). Leishmania promastigotes selectively inhibit interleukin-12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183, 515-526.
22. Chan, J., Fujiwara, T., Brennan, P., McNeil, M., Turco, S. J., Sibille, J., Snapper, M., Aisen, P. and Bloom, B. R. (1989). Microbial glycolipids: possible virulence factors that scavange oxygen radicals. Proc. Nat. Acad. Sci. USA 82, 5910-5914.
23. Chang, K. P. and Dwyer, D. M. (1976). Multiplication of a human parasite (Leishmania donovani) in the phagolysosomes of hamster macrophages in vitro. Science 193, 678-682.
24. Chang, K. P. (1981). Leishmania donovani macrophage binding mediated by surface glycoproteins/antigens. Mol. Biochem. Parasitol. 4, 67-71.
25. Channon, J. Y., Roberts, M. B. and Blackwell, J. M. (1984). A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages. Immunology 53, 345-355.
26. Chatelain, R., Varkila, K. and Coffman, R. L. (1992). IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148, 1182-1187.
27. Collins, H. L., Schaible, U. E., Ernst, J. D. and Russell, D. J. (1997). Transfer of phagocytosed particles to the parasitophorous vacuole of Leishmania mexicanas is a transient phenomenon preceding the acquisition of annexin 1 by the phagosome. J. Cell Sci. 110, 191-200.
28. Culley, F. J., Harris, R. A., Kaye, P. M., McAdam, K. P. W. J. and Raynes, J. G. (1996). C-reactive protein binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages. J. Immunol. 156, 4691-4696.
29. David, J., Soares, M., Satoskar, A., Brombacher, F., Shoemaker, C., Titus, R. and Bozza, M. (1997). Immunomodulatory properties of maxadilan, a peptide derived from sand fly saliva. Acta Parasitol. Turc. 21 (Suppl.), 174.
30. Davies, C. E., Cooper, A. M., Peacock, C., Lane, R. P. and Blackwell, J. M. (1990). Expression of LPG and GP63 by different development stages of Leishmania major in the sandfly, Phlebotomus papatasi. Parasitology 101, 337-343.
31. De Souza, L., Lang, T., Prina, E., Hellio, R. and Antoine, J.-C. (1995). Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. J. Cell Sci. 108, 3219-3231.
32. Descoteaux, A. and Matlashewski, G. (1989). c-fos and tumor necrosis factor gene expression in Leishmania donovani-infected macrophages. Mol. Cell. Biol. 9, 5223-5227.
33. Descoteaux, A., Luo, Y., Turco, S. J. and Beverly, S. M. (1995). A specialized pathway affecting virulence glycoconjugates of Leishmania. Science 269, 1869-1872.
34. Desjardins, M. and Descoteaux, A. (1997). Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J. Exp. Med. 185, 2061-2068.
35. Diefenbach, A., Schindler, H., Donhauser, N., Lorenz, E., Laskay, T., MacMicking, J., Rollinghoff, M., Gesser, I. and Bogdan, C. (1998). Type 1 interferon (IFNα/β) and Type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8, 77-87.
36. Engwerde, C. R., Murphy, M. L., Cotterell, S. E. J., Smelt, S. C. and Kaye, P. M. (1998). Neutralisation of IL-12 demonstrates the existence of discrete organ specific phases in the control of Leishmania donovani. Eur. J. Immunol. 28, 669-680.
37. Ferguson, M. A. J. (1997). The surface glycoconjugates of trypanosomatid parasites. Philos. Trans. R. Soc. London Ser. B 352, 1295-1302.
38. Frankenburg, S., Leibovici, V., Mansbach, N. and Turco, S. J. (1990). Effect of glycolipids of Leishmania parasites on human monocyte activity. J. Immunol. 145, 4284-4289.
39. Fruth, U., Solioz, N. M. and Louis, J. A. (1993). Leishmania major interferes with antigen presentation by infected macrophages. J. Immunol. 150, 1857-1863.
40. Futter, C. E., Felder, S., Schlessinger, J., Ullrich, A. and Hopkins, C. R. (1993). Annexin I is phosphorylated in the multivesicular body during the processing of the epidermal growth factor receptor. J. Cell Biol. 120, 77-83.
41. Giorgione, J. R., Turco, S. J. and Epand, R. M. (1996). Transbilayer inhibition of protein kinase. Proc. Nat. Acad. Sci. USA 93, 11634-11639.
42. Gorak, P. M., Engwerda, C. R. and Kaye, P. M. (1998). Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur. J. Immunol. 28, 687-695.
43. Green, P. J., Feizi, T., Stoll, M. S., Theil, S., Prescott, A. and McConville, M. J. (1994). Recognition of the major cell surface glycoconjugates of Leishmania parasites by the human serum mannan-binding protein. Mol. Biochem. Parasitol. 66, 319-328.
44. Gruenheid, S., Pinner, E., Desjardins, M. and Gros, P. (1997). Natural resistance to infection with intracellular pathogens: the Nramp 1 protein is recruited to the membrane of the phagosome. J. Exp. Med. 185, 717-730.
45. Guler, M. L., Gorham, J. D., Hsieh, C. S., Mackay, A. J., Steen, R. G., Dietrich, W. F. and Murphy, K. M. (1996). Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 271, 984-987.
46. Guranatha, S., Sacks, D. L., Brown, D. R., Reiner, S. L., Charest, H., Glaichenhaus, N. and Seder, R. A. (1997). Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J. Exp. Med. 186, 1137-1147.
47. Guy, R. A. and Belosevic, M. (1993). Comparison of receptors required for entry of Leishmania major amastigotes into macrophages. Infect. Immun. 61, 1553-1558.
48. Hall, L. R. and Titus, R. G. (1995). Sand fly saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production. J. Immunol. 155, 3501-3506.
49. Hansen, B. D., Webster, H. K., Hendricks, L. D. and Pappas, M. G. (1984). Leishmania mexicana: purine metabolism in promastigotes, axenic amastigotes and amastigotes derived from Vero cells. Exp. Parasitol. 58, 101-109.
50. Hatzigeorgiou, D. E., He, S., Sobel, J., Grabstein, K. H., Hafner, A. and Ho, J. L. (1993). IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages. J. Immunol. 151, 3682-3691.
51. Heinzel, F. P., Sadick, M. D., Holaday, B. J., Coffman, R. L. and Locksley, R. M. (1989). Reciprocal expression of interferon-γ or interleukin-4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T-cell subsets. J. Exp. Med. 169, 59-72.
52. Heinzel, F. P., Schoenhaut, D. S., Rerko, R. M., Rosser, L. E. and Gately, M. K. (1993). Recombinant interleukin-12 cures mice infected with Leishmania major. J. Exp. Med 177, 1505-1509.
53. Heinzel, F. P., Rerko, R. M., Ahmed, F. and Pearlman, E. (1995). Endogenous IL-12 is required for control of TH2 cytokine responses capable of exacerbating leishmanaisis in normally resistant mice. J. Immunol. 155, 730-739.
54. Heinzel, F. P., Rerko, R. M. and Hujer, A. M. (1998). Underproduction of interleukin-12 in susceptible mice during progressive leishmanisis is due to decreased CD40 activity. Cell. Immunol. 184, 129-142.
55. Huber, M., Timms, E., Mak, T. W., Rollinghoff, M. and Lohoff, M. (1998). Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice. Infect. Immun. 66, 3968-3970.
56. Jones, D., Elloso, M. M., Showe, L., Williams, D., Trinchieri, G. and Scott, P. (1998). Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major. Infect. Immun. 66, 3818-1824.
57. Julia, V., Rassoulzadegan, M. and Glaichenhaus, N. (1996). Resistance to Leishmania major induced by tolerance to a single antigen. Science 274, 421-423.
58. Juttner, S., Bernhagen, J., Metz, C. N., Rollinghoff, M., Bucala, R. and Gessner, A. (1998). Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. J. Immunol. 161, 2383-2390.
59. Kamanaka, M., Yu, P., Yasul, T., Yoshida, K., Kawabe, T., Morii, T., Kishimoto, T. and Kikutani, H. (1996). Protective role of CD40 in Leishmani major infection at two distinct phases of cell-mediated immunity. Immunity 4, 275-281.
60. Karp, C. L., El-Safi, S. H., Wynn, T. A., Satti, M. M. H., Kordofani, A. M., Hashim, F. A., Hag-Ali, M., Neva, F. A., Nutman, T. B. and Sacks, D. L. (1993). In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. J. Clin. Invest. 91, 1644-1648.
61. Kaye, P. M., Curry, A. J. and Blackwell, J. M. (1991). Differential production of Th1 and Th2-derived cytokines does not determine the genetically controlled vaccine induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146, 2763-2770.
62. Kaye, P. M., Rogers, N. J., Curry, A. J. and Scott, J. C. (1994). Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages. Eur. J. Immunol. 24, 2850-2854.
63. Kelleher, M., Moody, S. F., Mirabile, P., Osborn, A. H., Bacic, A. and Handman, E. (1995). Lipophosphoglycan blocks attachment of Leishmania major amastigotes to macrophages. Infect. Immun. 62, 43-50.
64. Kemp, M., Kurtzhals, J. A. L., Bendtzen, K., Poulsen, L. K., Hansen, M. B., Koech, D. K., Kharazmi, A. and Theander, T. G. (1993). Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect. Immun. 61, 1069-1073.
65. Kima, P. E., Soon, L., Chicharro, C., Ruddle, N. H. and McMahon-Pratt, D. (1996). Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells. Eur J. Immunol. 26, 3163-3169.
66. Kopf, M., Brombacher, F., Kohler, G., Kienzle, G., Widmann, K. H., Lefrang, K., Humborg, C., Ledermann, B. and Solbach, W. (1996). IL-4 deficient mice resist infection with Leishmania major. J. Exp. Med. 184, 1127-1136.
67. Kropf, P., Etges, R., Schopf, L., Chung, C., Sypek, J. and Muller, I. (1997). Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous IL-4. J. Immunol. 159, 3434-3443.
68. Kweider, M., Lesmesre, J., Darcy, F., Kusnierz, J., Capron, A. and Santoro, F. (1987). Infectivity of Leishmania braziliensis promastigotes is dependent on the increasing expression of a 65,000 dalton surface antigen. J. Immunol. 138, 299-305.
69. Lang, T., de Chastellier, C., Frehel, C., Hellio, R., Metezeau, P., de Souze Leao, S. and Antoine, J.-C. (1994). Distribution of MHC class I and MHC class II molecules in macrophages infected with Leishmania amazonensis. J. Cell Sci. 107, 69-82.
70. Launois, P., Maillard, I., Pingel, S., Swihart, K. G., Xenarios, I., Acha-Orbea, H., Diggelmann, H., Locksley, R. M., MacDonald, H. R. and Louis, J. A. (1997). IL-4 rapidly produced Vb4Va8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6, 541-549.
71. Leal, L. M., Moss, D. M., Kuhn, R., Muller, W. and Liew, F. Y. (1993). Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major. Eur. J. Immunol. 23, 566-569.
72. Liew, F. Y., Li, Y. and Millott, S. (1990). Tumour necrosis factor-α synergises with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145, 4306-4310.
73. Liew, F. Y. and O'Donnell, C. A. (1993). Immunology of leishmaniasis. Adv. Parasitol. 32, 161-259.
74. Lima, H. C. and Titus, R. G. (1996). Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice. Infect. Immun. 64, 5442-5445.
75. Lo, S. K., Bovis, L., Matura, R., Zhu, B., He, S., Lum, H., Turco, S. J. and Ho, J. L. (1998). Leishmania lipophosphoglycan reduces monocyte transendothelial migration: modulation of cell adhesion molecules, intercellular junctional proteins, and chemo-attractants. J. Immunol. 160, 1857-1865.
76. Locksley, R. M., Reiner, S. L., Hatam, F., Littman, D. R. and Killeen, N. (1993). Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261, 1448-1451.
77. Love, D. C., Esko, J. D. and Mosser, D. M. (1993). A heparin-binding activity on Leishmania amastigotes which mediates adhesion to cellular proteoglycans. J. Cell Biol. 123, 759-766.
78. Macatonia, S. E., Hsieh, C. S., Murphy, K. M. and O'Garra, A. (1993). Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from alpha beta TCR transgenic mice: IL-12 substitution from macrophages to stimulate IFN-gamma production is IFN-gamma-dependent. Int. Immunol. 5, 1119-1128.
79. Mallinson, D. J. and Coombs, G. H. (1989). Biochemical characteristics of the metacyclic forms of Leishmania major and Lmexicana mexicana. Parasitology 98, 7-15.
80. Mannheimer, S. B., Hariprashad, J., Stoeckle, M. Y. and Murray, H. W. (1996). Induction of macrophage antiprotozoal activity by monocyte chemotactic and activating factor. FEMS Immunol. 14, 59-61.
81. McConville, M. J. and Blackwell, J. M. (1991). Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids. J. Biol. Chem. 266. 15170-15179.
82. McConville, M. J., Collidge, T. A. C., Ferguson, M. A. J. and Schneider, P. (1993). The glycoinositolphospholipids of Leishmania mexicana promastigotes: evidence for the presence of three distinct pathways of biosynthesis. J. Biol. Chem. 268, 15595-15604.
83. McNeely, T. B., Rosen, G., Londner, M. V. and Turco, S. J. (1989). Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphosphatidyl-inositol antigens of the protozoan parasite Leishmania. Biochem. J. 259, 601-604.
84. Medina-Acosta, E., Karess, R. E., Schwartz, R. and Russell, D. G. (1989). The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed and localized in the amastigote stage. Mol. Biochem. Parasitol. 37, 263-274.
85. Miralles, G. D., Stoeckle, M. Y., McDermott, D. F., Finkelman, F. D. and Murray, H. W. (1994). Th1 and Th2 cell associated cytokines in experimental visceral leishmaniasis. Infect. Immun. 62, 1058-1063.
86. Moll, H., Fuchs, H., Blank, C. and Rollinghoff, M. (1993). Langerhans cells transport Leishmania major from infected skin to the draining lymph node for presentation to antigen-specifc T cells. Eur. J. Immunol. 23, 1595-1601.
87. Moll, H., Ritter, U., Flohe, S., Erb, K., Bauer, C. and Blank, C. (1996). Cutaneous leishmaniasis: a model for analysis of the immuno-regulation by accessory cells. Med. Microbiol. Immunol. 184, 163-168.
88. Moody, S. F., Handman, E., McConville, M. J. and Bacie, A. (1993). The structure of Leishmania major amastigote lipophosphoglycan. J. Biol. Chem. 268, 18457-18466.
89. Moore, K. J. and Matlashewski, G. (1994). Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J. Immunol. 152, 2930-2937.
90. Mosser, D. M., Vlassara, H., Edelson, P. J. and Cerami, A. (1989). Leishmania promastigotes are recognized by the macrophage receptor for advanced glycosylation endproducts. J. Exp. Med. 165, 140-145.
91. Mosser, D. M. and Rosenthal, L. A. (1993). Leishmania-macrophage interaction: multiple receptors, multiple ligands, and diverse cellular responses. Semin. Cell Biol. 40, 63-76.
92. Mosser, D. A. and Rosenthal, L. A. (1994). Divergent strategies used by the promastigote and amastigote forms of Leishmania to invade mammalian cells. Baillières Clin. Infect. Dis. 1, 191-212.
93. Mottram, J. C., Brooks, D. R. and Coombs, G. H. (1998). Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions. Curr. Opin. Microbiol. 1, 455-460.
94. Murphy, M. L., Engwerda, C. R., Gorak, P. M. A. and Kaye, P. M. (1997). B7-2 blockade enhances T cell responses to Leishmania donovani. J. Immunol. 159, 4460-4466.
95. Murphy, M., Cotterell, S. E. J., Gorak, P. M., Engwerde, C. R. and Kaye, P. M. (1998). Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani. J. Immunol. 161, 4153-4160.
96. Nabors, G. S., Alfonso, L. C. C., Farrell, J. P. and Scott, P. (1995). Switch from a type-2 to a type-1 T-helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin-12 and pentostam. Proc. Nat. Acad. Sci. USA 92, 3142-3146.
97. Noben-Trauth, N., Kopf, P. and Muller, I. (1996). Susceptibility to Leishmania major in interleukin-4 deficient mice. Science 271, 987-990.
98. Peidrafita, D., Proudfoot, L., Nikolaev, A. V., Xu, D., Sands, W., Feng, G.-J., Thomas, E., Brewer, J., Ferguson, M. A. J., Alexander, J. and Liew, F. Y. (1999). Regulation of interleukin 12 synthesis in macrophages by Leishmania phosphoglycans. Eur. J. Immunol. 29, 235-244.
99. Peters, C., Aebischer, T., Stierhof, Y.-D., Fuchs, M. and Overath, P. (1995). The role of macrophage receptors in adhesion and uptake of Leishmania mexicana amastigotes. J. Cell Sci. 108, 3715-3724.
100. Pimenta, P. F. P., Saraiva, E. M. B. and Sacks, D. L. (1991). The fine structure and surface glycoconjugate expression of three life stages of Leishmania major. Exp. Parasitol. 72, 191-204.
101. Prina, E., Antoine, J. C., Weideranders, B. and Kirschke, H. (1990). Localization and activity of various lysosomal proteases in Leishmania amazonensis infected macrophages. Infect. Immun. 58, 1730-1737.
102. Prina, E., Jouanne, C. and de Souza Lao, S. (1993). Antigen presentation capacity of murine macrophages infected Leishmania amazonensis amastigotes. J. Immunol. 151, 2050-2061.
103. Prina, E., Lang, T., Glaichenhaus, N. and Antoine, J.-C. (1996) Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages. J. Immunol. 156, 4318-4327.
104. Proudfoot, L., O'Donnell, C. A. and Liew, F. Y. (1995). Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages. Eur. J. Immunol. 25, 745-750.
105. Proudfoot, L., Nikolaev, A. V., Feng, G. J., Wei, X. Q., Ferguson, M. A. J., Brimacombe, J. S. and Liew, F. Y. (1996). Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lysophosphoglycan in murine macrophages. Proc. Nat. Acad. Sci. USA 93, 10984-10989.
106. Puentas, S. M., da Silva, R. P., Sacks, D. L., Hammer, C. H. and Joiner, K. A. (1991). Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5-9. J. Immunol. 145, 4311-4416.
107. Ramamoorthy, R., Donelson, J. E., Paetz, K. E., Maybodi, M., Roberts, S. C. and Wilson, M. E. (1992). Three distinct RNAs for the surface protease gp63 are differentially expressed during development Leishmania donovani chagasi promastigotes to an infectious form. J. Biol. Chem. 267, 1888-1895.
108. Reiner, N. E., Ng, W. and McMaster, W. R. (1987). Parasite accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. J. Immunol. 138, 1926-1932.
109. Reiner, N. E., Ng, W., Wilson, C. B., McMaster, W. R. and Burchett, S. K. (1990). Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-γ presents parasite-induced inhibition of interleukin I production and prime tumor necrosis factor-x and interleukin 1. J. Clin. Invest. 85, 1914-1924.
110. Reiner, S. L., Zheng, S., Wang, Z. E., Stowring, L. and Locksley, R. M. (1994). Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J. Exp. Med. 179, 447-456.
111. Rizvi, F. S., Quassi, M. A., Marty, B., Santoro, F. and Capron, A. (1988). The major surface protein Leishmania promastigotes in a fibronectin-like molecule. Eur. J. Immunol. 18, 473-476.
112. Rodrigues, V., Santana da Silva, J. and Campos-Neto, A. (1998). Transforming growth factor beta and immunosupression in experimental visceral leishmaniasis. Infect. Immun. 66, 1233-1236.
113. Rosat, J. P., McDonald, H. R. and Louis, J. A. (1993). A role for γδ T cells during experimental infection of mice with Leishmania major. J. Immunol. 150, 550-555.
114. Russell, D. G. and Wilhelm, H. (1986). The involvement of a major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages. J. Immunol. 136, 2613-2620.
115. Russell, D. G. and Alexander, J. (1988). Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. J. Immunol. 140, 1274-1279.
116. Russell, D. G., Xu, S. and Chakraborty, P. (1992). Intracellular trafficking and the parasitophorous vacuole of Leishmania mexicana-infected macrophages. J. Cell Sci. 103, 1193-1210.
117. Russell, D. G. (1994). Biology of the Leishmania surface: with particular reference to the surface proteinase gp63. Protoplasma 181, 191-201.
118. Russell, D. G. (1995). Leishmania and Mycobacterium: stowaways in the endosomal network. Trends Cell Biol. 5, 125-128.
119. Sacks, D. L. and Perkins, P. V. (1985). Development of infective stage Leishmania promastigotes within phlebotomine sandflies. Am. J. Trop. Med. Hyg. 34, 456-459.
120. Sacks, D. L., Pimenta, P. F., McConville, M. J., Schneider, P. and Turco, S. J. (1995). Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan. J. Exp. Med. 181, 685-697.
121. Saha, B., Das, G., Vohra, H., Ganguly, N. K. and Mishra, G. C. (1995). Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell mediated immunity. Eur. J. Immunol. 25, 2492-2498.
122. Saraiva, E. M., Pimenta, P. F., Brodin, T. N., Rowton, E., Modi, G. B. and Sacks, D. L. (1995). Changes in lipophosphoglycan and gene expression associated with the development of Leishmania major in Phlebotomus papatasi. Parasitology 111, 275-287.
123. Sartori, A., Oliveira, M. A. P., Scott, P. and Trinchieri, G. (1997). Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells. J. Immunol. 159, 2849-2857.
124. Satoskar, A. and Alexander, J. (1995). Sex-determined susceptibility and differential IFN-gamma and TNF-alpha mRNA expression in DBA/2 mice infected with Leishmania mexicana. Immunology 84, 1-4.
125. Satoskar, A., Bluethmann, H. and Alexander, J. (1995). Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infec. Immun. 63, 4894-4899.
126. Satoskar, A., Okano, M. and David, J. R. (1997a). γδ T cells are not essential for control of cutaneous Leishmania major infection in genetically resistant C57BL/6 mice. J. Infect. Dis. 176, 1649-1652.
127. Satoskar, A., Brombacher, F., Dai, W. J., McInnes, I., Liew, F. Y., Alexander, J. and Walker, W. (1997b). SCID mice reconstituted with IL-4 deficient lymphocytes, but not immunocompetent lymphocytes, are resistant to cutaneous leishmaniasis. J. Immunol. 159, 5005-5013.
128. Satoskar, A. R., Okano, M., Connaughton, S., Raisanen-Sokolwski, A., David, J. R. and Labow, M. (1998). Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice. Eur. J. Immunol. 28, 2066-2074.
129. Schaible, U. E., Schlesinger, P. H., Steinberg, T. H., Mangel, W. F., Kobayashi, T. and Russell, D. G. (1999). Parasitophorous vacuoles of Leishmania mexicana acquire macromolecules from the host cell cytosol via two independent routes. J. Cell Sci. 112, 681-693.
130. Scharton-Kersten, T., Afonso, L. C. C., Wysocka, M., Trinchieri, G. and Scott, P. (1995). IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154, 5312-5330.
131. Scott, P., Eaton, A., Gause, W. C., di Zhou, X. and Hondowicz, B. (1996). Early IL-4 production does not predict susceptibility to Leishmania major. Exp. Parasitol. 84, 178-187.
132. Seay, M. B., Heard, P. L. and Chaudhari, G. (1996). Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonenesis promastigotes against cytolysis inside macrophage phagolysosomes. Infect. Immun. 64, 5129-5137.
133. Soares, M. B. P., Titus, R. G., Schoemaker, C. B., David, J. R. and Bozza, M. (1998). The vasoactive peptide maxadilan from sandfly saliva inhibits TNF-α and induces IL-6 by mouse macrophages through interaction with the PACAP receptor. J. Immunol. 160, 1811-1816.
134. Soong, L., Xu, J.-C., Grewal, I. S., Kima, P., Sun, J., Longley, B. J., Ruddle, N. H., McMahon-Pratt, D. and Flavell, R. A. (1996). Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4, 263-273.
135. Sorensen, A. L., Hey, A. S. and Kharazmi, A. (1994). Leishmania major surface protease gp63 interferes with the function of human monocytes and neutrophils in vitro. APMIS 102, 265-271.
136. Stamm, L., Raisanen-Sokolwski, A., Okano, M., Russell, M. E., David, J. R. and Satoskar, A. R. (1998). Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis. J. Immunol. 161, 6180-6188.
137. Stenger, S., Thuring, H., Rollinghoff, M. and Bogdan, C. (1994). Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180, 783-793.
138. Sturgill-Koszycki, S., Schlessinger, P. H., Chakraborty, P., Haddix, P. L., Collins, H. L., Fok, A. K., Allen, R. D., Gluck, S. L., Heuser, J. and Russell, D. G. (1994). Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263, 678-681.
139. Sundar, S. and Murray, H. W. (1997). Immunotherapy using interferon-gamma in Indian kala azar. Acta Parasitol. Turc. 21, S1-78.
140. Sypek, J. P., Chung, C. L., Mayor, S. E. H., Subramanyam, J. M., Goldman, S. J., Sieburth, D. S., Wolf, S. F. and Schaub, R. G. (1993). Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177, 1797-1802.
141. Talamas-Rohana, P., Wright, S. D., Lennartz, M. and Russell, D. G. (1990). Lipophophoglycan (LPG) of Leishmania mexicana promastigotes binds to the CR3, p150/95 and LFA-1 family of leukocyte integrins. J. Immunol. 144, 4817-4824.
142. Taylor, A. P. and Murray, H. W. (1997). Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice. J. Exp. Med. 185, 1231-1239.
143. Theodos, C. M., Shankar, A., Glasebrook, A. L., Roeder, W. D. and Titus, R. G. (1994). The effect of treating with anti-interleukin-1 receptor antibody on the course of experimental murine cutaneous leishmaniasis. Parasite Immunol. 16, 571-577.
144. Turco, S. J. and Sacks, D. L. (1991). Expression of a stage-specific lipophosphoglycan in Leishmania major. Mol. Biochem. Parasitol. 45, 91-99.
145. Turco, S. J. and Descoteaux, A. (1992). The lipophosphoglycan of Leishmania parasites. Annu. Rev. Microbiol. 46, 65-94.
146. Veras, P. S. T., de Chastellier, C. and Rabinovitch, M. (1992). Transfer of zymosan (yeast cell walls) to the parasitophorous vacuoles of macrophages infected with Leishmania amazonensis. J. Exp. Med. 176, 639-646.
147. Vouldoukis, I., Riveros-Moreno, V., Dugas, B., Ouaaz, F., Becherel, P., Debre, P., Salvador, M. and Mossalayi, M. D. (1995). The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FcandRII/Cd23 surface antigen. Proc. Nat. Acad. Sci. USA 92, 7804-7808.
148. Vouldoukis, I., Becherel, P. A., Riveros-Moreno, V., Arock, M., da Silva, O., Debre, P., Mazier, D. and Mossalayi, M. D. (1997) Interleukin-10 and interleukin-4 inhibits intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur. J. Immunol. 27, 860-865.
149. Weinheber, N., Wolfram, M., Harbecke, D. and Aebischer, T. (1998). Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12. Eur. J. Immunol. 28, 2467-2477.
150. Wilson, M. E. and Pearson, R. D. (1986). Evidence that Leishmania donovani utilises a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism. J. Immunol. 136, 4681-4687.
151. Wolfranm, M., Fuchs, M., Wiese, M., Stierhof, Y.-D. and Overath, P. (1996). Antigen presentation by Leishmania mexicana infected macrophages: activation of helper T cells by a model parasite antigen secreted into the parasitophorous vacuole or expressed on the amastigote surface. Eur. J. Immunol. 26, 3153-3162.
152. Wyler, D. J., Sypec, J. P. and McDonald, J. A. (1985). In vitro parasite monocyte interactions in human leishmaniasis: possible role of fibronectin in parasite atttachment. Infect. Immun. 49, 305-311.
153. Xu, D., McSorley, S. J., Tetley, L., Chatfield, S., Dougan, G., Chan, W. L., Satoskar, A., David, J. R. and Liew, F. Y. (1998). Protective effect on Leishmania major infection of migration inhibitory factor, TNF-α, and IFN-γ administered orally via attenuated Salmonella typhimurium. J. Immunol. 160, 1285-1289.
154. Yoshimoto, T., Ohkusu, K., Okamura, H. and Nakanishi, K. (1998). Induction of host resistance to Leishmania major by IL-12 and IL-18: in vivo IL-12 treatment upregulates IL-18 receptor expression of T cells. FASEB J. 12, A1068.